JP

John Pacifico

General Partner at Canaan Partners

New York City Metropolitan Area

Overview 

John Pacifico is the President, Chief Executive Officer, and Board Member of Abyrx, Inc., with a background in Venture Capital and Lifesciences. He has successfully led Abyrx, Inc., and previously served as a General Partner at Canaan Partners, showcasing expertise in business development and commercialization within the pharmaceutical industry. Pacifico's career highlights include serving as the Founder and Chairman of Kairuku, Inc., and as President, Chief Executive Officer, and Member of the Board of Directors at ORTHOCON, demonstrating a strong track record in founding and leading successful start-ups in the medical devices sector.

Work Experience 

C

Canaan

  • General Partner

    2018 - Current

    Early-stage venture capital investment firm.

Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas.

canaan.com
A

Abyrx

  • President, Chief Executive Officer, and Member of the Board of Directors

    2013

    Developer of biosurgical technologies.

Abyrx develops, manufactures, and provides specialty biosurgical products for use during surgical procedures

Raised $10,000,000.00 from BB Biotech Ventures, Canaan Partners and MedEdge.

abyrx.com

Kairuku, Inc.

  • Founder and Chairman

    2013

    SaaS solution to optimize distribution of medical products and information share.

PrimeFour Therapeutics

  • Board Member

    2021

    Developing new pharmaceuticals to treat cancers.

Transposon Therapeutics

  • Board Member

    2020

    Developing new pharmaceuticals to treat neurodegenerative disorders.

A

Aceiss

  • Board Member

    2021

    Cybersecurity company enabling continuous / real-time visibility and insights into user access across enterprise technology systems.

Aceiss instantly starts delivering insights after plugging into your current application and security infrastructure.

Raised $3,250,000.00 from Canaan Partners, Connecticut Innovations and Insight Partners.

aceiss.com

ORTHOCON

  • President, Chief Executive Officer, and Member of the Board of Directors

    2007 - 2013

    Targeted drug delivery products for use during surgical procedures.

ORTHOCON is a medical therapeutics company developing absorbable products for orthopaedic and spine surgeries.

Raised $47,500,000.00 from ProQuest Investments and Canaan Partners.

orthocon.com
C

Canaan

  • Venture Capitalist

    2000 - 2007

    Early-stage venture capital investment firm.

Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas.

canaan.com

Education 

Investments 

Aceiss

Seed

Total funding: $3M

Articles About John

Relevant Websites